Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 5/20 | 0.33 |
| ▸ | PRKCA | P17252 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8853823 | 1.00 | ATM (0.53) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL3482740 | 0.93 | HCAR2 (0.59) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9242316 | 0.93 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9242304 | 0.93 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL3482742 | 0.93 | HCAR2 (0.59) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL8733190 | 0.93 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9244986 | 0.93 | ATM (0.52) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9245022 | 0.93 | ATM (0.52) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL10025714 | 0.92 | ATM (0.46) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL35808 | 0.91 | ATM (0.44) | ATMHCAR2MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015099-A1 | NON BIO-ADHESIVE POLYMER COATING COMPOSITION, ARTICLES AND DEVICES THEREOF | GENERAL ELECTRIC COMPANY (US) | 2011-01-20 | — | — | US | claimed |
| JP-62039589-A | — | — | None | — | — | JP | disclosed |
| JP-10251352-A | — | — | None | — | — | JP | disclosed |
| JP-9077831-A | — | — | None | — | — | JP | disclosed |
| US-12428390-B2 | Chromene compound and photochromic optical article | TOKUYAMA CORPORATION (JP) | 2025-09-30 | — | — | US | disclosed |
| EP-3822296-B1 | POLYMER MATERIAL | MENICON CO LTD (JP) | 2025-09-10 | — | — | EP | disclosed |
| WO-2025094241-A1 | COMPOSITE MEMBRANE | 株式会社メニコン | 2025-05-08 | — | — | WO | disclosed |
| US-20250115701-A1 | POLYMER MATERIAL | MENICON CO., LTD. (JP) | 2025-04-10 | — | — | US | disclosed |
| US-12239527-B2 | Method of absorbing or discharging water of ophthalmic medical device and ophthalmic medical device | TOHOKU UNIVERSITY (JP) | 2025-03-04 | — | — | US | disclosed |
| US-12209154-B2 | Polymer material | MENICON CO., LTD. (JP) | 2025-01-28 | — | — | US | disclosed |
| EP-0524557-A2 | Ocular lens material | Menicon Co., Ltd. (JP) | 1993-01-27 | — | — | EP | disclosed |
| US-5142009-A | Crosslinked blend of fumaric acid diesters | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-08-25 | — | — | US | disclosed |
| US-5134213-A | N-Vinyllactam-Monoperoxyfumarate Terpolymer | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-07-28 | — | — | US | disclosed |
| US-5082912-A | For graft polymerization, surfactants | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-01-21 | — | — | US | disclosed |
| EP-0434362-A1 | Graft copolymer, solution containing the graft copolymer, and method of treating contact lens with the solution | Tomei Sangyo Kabushiki Kaisha (JP) | 1991-06-26 | — | — | EP | disclosed |
| EP-0433046-A2 | Polymer-type polymerization initiator | Tomei Sangyo Kabushiki Kaisha (JP) | 1991-06-19 | — | — | EP | disclosed |
| US-4868260-A | OXYGEN PERMEABILITY | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0219884-A2 | Hard contact lens material | Tomei Sangyo Kabushiki Kaisha (JP) | 1987-04-29 | — | — | EP | disclosed |
| EP-0215435-A1 | 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-03-25 | — | — | EP | disclosed |
| JP-S6239589-A | BIS(SILOXANYLALKYL)FUMARATE AND PRODUCTION THEREOF | SEIKO EPSON CORP | 1987-02-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428390-B2 | Chromene compound and photochromic optical article | CRY1, CRY2, RAD51 | ATM 908/4885HCAR2 3379/4885MAPT 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.